How do TKI inhibitors work?

How do TKI inhibitors work?

Tyrosine kinase inhibitors (TKIs) block chemical messengers (enzymes) called tyrosine kinases. Tyrosine kinases help to send growth signals in cells, so blocking them stops the cell growing and dividing. Cancer growth blockers can block one type of tyrosine kinase or more than one type.

What type of inhibitor is tyrosine kinase inhibitor?

A tyrosine kinase inhibitor (TKI) is a pharmaceutical drug that inhibits tyrosine kinases. Tyrosine kinases are enzymes responsible for the activation of many proteins by signal transduction cascades. The proteins are activated by adding a phosphate group to the protein (phosphorylation), a step that TKIs inhibit.

What is TKI CML?

TKIs come as pills, taken orally. A targeted therapy identifies and attacks specific types of cancer cells while causing less damage to normal cells. In CML, TKIs target the abnormal BCR-ABL1 protein that causes uncontrolled CML cell growth and block its function, causing the CML cells to die.

Can CML be cured completely?

With modern treatments, it’s often possible to control chronic myeloid leukaemia (CML) for many years. In a small number of cases, it may be possible to cure it completely.

Does CML cause hair loss?

Skin and hair Chemotherapy drugs work by destroying fast-growing cells. A variety of these drugs are used to treat CML. Some, but not all, can lead to temporary hair loss.

How does TKI work CML?

They work by switching off (inhibiting) the tyrosine kinase made by the BCR-ABL1 gene in leukaemia cells. This slows or stops the bone marrow from making abnormal white blood cells. It also allows the leukaemia cells to mature and die. There are many different TKIs for CML.

Is dasatinib a TKI?

Dasatinib (Sprycel) is another TKI that targets the BCR-ABL protein. Because it was developed after imatinib, it’s called a second-generation TKI.

Are TKI chemotherapy?

Any drug used to treat cancer (including tyrosine kinase inhibitors or TKIs) can be considered chemo, but here chemo is used to mean treatment with conventional cytotoxic (cell-killing) drugs that mainly kill cells that are growing and dividing rapidly. Chemo was once one of the main treatments for CML.

What kind of kinases does K252a inhibit?

K252a is a reversible cell-permeable, potent inhibitor of phosphorylase kinase (IC 50 = 1.7 nM), protein kinase A (PKA) (IC 50 = 140 nM), and protein kinase C (PKC) (IC 50 = 470 nM) (3,4). K252a is also known to inhibit protein kinase G and CaM kinase II (5,6).

Where does the drug K252a come from?

Originally isolated from the soil fungi Nocardiopisis sp., K252a is a staurosporine analog that inhibits various protein kinases through competition with the ATP binding site (1,2).

How is K252a used in the treatment of PC12?

K252a, an efficient serine/threonine protein kinase inhibitor (IC50s of 10 to 30 nM), has been shown to block the neuronal differentiation of rat pheochromocytoma PC12 cells induced by nerve growth factor (NGF).

When to use K252a as a pretreatment?

K252a is supplied as a lyophilized powder. For a 1 mM stock, reconstitute the 100 μg in 213.9 µl DMSO. Working concentrations and length of treatment can vary depending on the desired effect, but it is typically used as a pretreatment at 0.1-1 µM for 0.5-1 hr prior to treating with a stimulator.